23 related articles for article (PubMed ID: 29726580)
1. Impact of the HLA Immunopeptidome on Survival of Leukemia Patients After Unrelated Donor Transplantation.
Crivello P; Arrieta-Bolaños E; He M; Wang T; Fingerson S; Gadalla SM; Paczesny S; Marsh SGE; Lee SJ; Spellman SR; Bolon YT; Fleischhauer K
J Clin Oncol; 2023 May; 41(13):2416-2427. PubMed ID: 36669145
[TBL] [Abstract][Full Text] [Related]
2. Reduced human leukocyte antigen mismatching is associated with more favourable outcomes after unrelated donor haematopoietic stem cell transplantation.
Valatkaite-Rakstiene B; Cekauskiene R; Zvirblis T; Jakubauskas A
Int J Immunogenet; 2024 Apr; 51(2):63-71. PubMed ID: 38183417
[TBL] [Abstract][Full Text] [Related]
3. SOHO State of the Art Updates and Next Questions | Current Status and Future Directions of Donor Selection.
Mehta RS
Clin Lymphoma Myeloma Leuk; 2024 May; ():. PubMed ID: 38825445
[TBL] [Abstract][Full Text] [Related]
4. Optimal Donor Selection Across Multiple Outcomes For Hematopoietic Stem Cell Transplantation By Bayesian Nonparametric Machine Learning.
Sparapani RA; Maiers M; Spellman SR; Shaw BE; Laud PW; Devine SM; Logan BR
medRxiv; 2024 May; ():. PubMed ID: 38766030
[TBL] [Abstract][Full Text] [Related]
5. Distributions of the HLA-A, HLA-B, HLA-C, HLA-DRB1, and HLA-DQB1 alleles and haplotype frequencies of 1763 stem cell donors in the Colombian Bone Marrow Registry typed by next-generation sequencing.
Hernández-Mejía DG; Páez-Gutiérrez IA; Dorsant Ardón V; Camacho Ramírez N; Mosquera M; Cendales PA; Camacho BA
Front Immunol; 2022; 13():1057657. PubMed ID: 36700199
[TBL] [Abstract][Full Text] [Related]
6. Human Leucocyte Antigen System and Selection of Unrelated Hematopoietic Stem Cell Donors: Impact of Patient-Donor (Mis)matching and New Challenges with the Current Technologies.
Crocchiolo R; Rombolà G
J Clin Med; 2023 Jan; 12(2):. PubMed ID: 36675576
[TBL] [Abstract][Full Text] [Related]
7.
Tsamadou C; Engelhardt D; Platzbecker U; Sala E; Valerius T; Wagner-Drouet E; Wulf G; Kröger N; Murawski N; Einsele H; Schaefer-Eckart K; Freitag S; Casper J; Kaufmann M; Dürholt M; Hertenstein B; Klein S; Ringhoffer M; Frank S; Neuchel C; Schrezenmeier H; Mytilineos J; Fuerst D
Front Immunol; 2021; 12():771449. PubMed ID: 34970261
[TBL] [Abstract][Full Text] [Related]
8. Clinical implications of HLA locus mismatching in unrelated donor hematopoietic cell transplantation: a meta-analysis.
Tie R; Zhang T; Yang B; Fu H; Han B; Yu J; Tan Y; Huang H
Oncotarget; 2017 Apr; 8(16):27645-27660. PubMed ID: 28206973
[TBL] [Abstract][Full Text] [Related]
9. HLA-DRB3/4/5 mismatches are associated with increased risk of acute GVHD in 10/10 matched unrelated donor hematopoietic cell transplantation.
Ducreux S; Dubois V; Amokrane K; Yakoub-Agha I; Labalette M; Michallet M; Rubio MT; Kennel A; Forcade E; Lafarge X; Bulabois CE; Masson D; Daguindau E; Devys A; Moalic V; Quelvennec E; Boudifa A; Picard C; Van Endert P; de Matteis M; Delbos F; Filloux M; Pedron B; Renac V; Hau F; Bonneau J; Parissiadis A; Fort M; Dormoy A; Maillard N; Jollet I; Chevallier P; Cesbron A; Bay JO; Quainon F; Garnier F; Socié G; Loiseau P; Porcher R; Peffault de Latour R;
Am J Hematol; 2018 May; ():. PubMed ID: 29726580
[TBL] [Abstract][Full Text] [Related]
10. Effect of nonpermissive HLA-DPB1 mismatches after unrelated allogeneic transplantation with in vivo T-cell depletion.
Oran B; Saliba RM; Carmazzi Y; de Lima M; Rondon G; Ahmed S; Alousi A; Andersson BS; Anderlini P; Alvarez M; Bashir Q; Ciurea S; Fernandez-Vina M; Hosing C; Kebriaei P; Korbling M; Cano P; Khouri I; Marin D; Nieto Y; Olson A; Popat U; Rezvani K; Qazilbash M; Shpall EJ; Champlin RE; Cao K
Blood; 2018 Mar; 131(11):1248-1257. PubMed ID: 29386198
[TBL] [Abstract][Full Text] [Related]
11. Role of HLA-DP Expression in Graft-Versus-Host Disease After Unrelated Donor Transplantation.
Petersdorf EW; Bengtsson M; De Santis D; Dubois V; Fleischhauer K; Gooley T; Horowitz M; Madrigal JA; Malkki M; McKallor C; Morishima Y; Oudshoorn M; Spellman SR; Villard J; Stevenson P; Carrington M; ;
J Clin Oncol; 2020 Aug; 38(24):2712-2718. PubMed ID: 32479188
[TBL] [Abstract][Full Text] [Related]
12. High-resolution HLA matching in unrelated donor transplantation in Switzerland: differential impact of class I and class II mismatches may reflect selection of nonimmunogenic or weakly immunogenic DRB1/DQB1 disparities.
Passweg JR; Schanz U; Chalandon Y; Güngör T; Baldomero H; Heim D; Nair G; Medinger M; Masouridi-Levrat S; de Faveri GN; Tiercy JM;
Bone Marrow Transplant; 2015 Sep; 50(9):1201-5. PubMed ID: 26052916
[TBL] [Abstract][Full Text] [Related]
13. Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study.
Fleischhauer K; Shaw BE; Gooley T; Malkki M; Bardy P; Bignon JD; Dubois V; Horowitz MM; Madrigal JA; Morishima Y; Oudshoorn M; Ringden O; Spellman S; Velardi A; Zino E; Petersdorf EW;
Lancet Oncol; 2012 Apr; 13(4):366-74. PubMed ID: 22340965
[TBL] [Abstract][Full Text] [Related]
14. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
